Cyclopenthiazide

Chemical compound
  • C03AA07 (WHO)
Legal statusLegal status
  • UK: POM (Prescription only)
Identifiers
  • 6-chloro-3-(cyclopentylmethyl)-1,1-dioxo-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide
CAS Number
  • 742-20-1
PubChem CID
  • 2904
IUPHAR/BPS
  • 7899
ChemSpider
  • 2801
UNII
  • VX4S2N85F5
KEGG
  • D02061 checkY
ChEMBL
  • ChEMBL1373254
CompTox Dashboard (EPA)
  • DTXSID4022868 Edit this at Wikidata
ECHA InfoCard100.010.920 Edit this at WikidataChemical and physical dataFormulaC13H18ClN3O4S2Molar mass379.87 g·mol−13D model (JSmol)
  • Interactive image
  • O=S(=O)(c1c(Cl)cc2c(c1)S(=O)(=O)NC(N2)CC3CCCC3)N
InChI
  • InChI=1S/C13H18ClN3O4S2/c14-9-6-10-12(7-11(9)22(15,18)19)23(20,21)17-13(16-10)5-8-3-1-2-4-8/h6-8,13,16-17H,1-5H2,(H2,15,18,19)
  • Key:BKYKPTRYDKTTJY-UHFFFAOYSA-N
  (verify)

Cyclopenthiazide (trade name Navidrex) is a thiazide diuretic used in the treatment of heart failure and hypertension.

Synthesis

Cyclopenthiazide synthesis:[1]

Contraindications

Thiazide diuretics increase the excretion of sodium and potassium ions and decrease the excretion of calcium ions and uric acid so they are contraindicated in patients with hyponatraemia, hypokalaemia, hypercalcaemia and hyperuricaemia. They are also contraindicated in patients with Addison's disease.

See also

  • v
  • t
  • e
Sulfonamides
(and etacrynic acid)
CA inhibitors (at PT)
Loop (Na-K-Cl at AL)
Thiazides (Na-Cl at DCT,
Calcium-sparing)
Thiazide-likes (primarily DCT)
Potassium-sparing (at CD)
ESC blockers
Aldosterone antagonists
Osmotic diuretics (PT, DL)
Vasopressin receptor inhibitors
(DCT and CD)
Other
Combination products

References

  1. ^ Whitehead CW, Traverso JJ, Sullivan HR, Marshall FJ (1961). "Diuretics. V. 3,4-Dihydro-1,2,4-benzothiadiazine 1,1-Dioxides". The Journal of Organic Chemistry. 26 (8): 2814–2818. doi:10.1021/jo01066a046.


Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e